ESI Stock Analysis: Element Solutions | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 9.087m USD | 12M Return: 42.8% | US28618M1062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 134M
EPS Trend: 96.7%
Qual. Beats: 3
Rev. Trend: 84.9%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Element Solutions Inc (ESI) is a specialty chemicals technology company headquartered in Miami Beach, Florida, with operations in the United States, China, and other international markets. The company is organized into two reporting segments: MacDermid Alpha Electronics Solutions, which supplies assembly, circuitry, and semiconductor packaging materials to mobile communications, computing, automotive, and aerospace equipment manufacturers; and Element Specialties, which provides industrial finishing products (such as electroless nickel, plating, and pre-treatment solutions) and energy-sector fluids to aerospace, automotive, construction, consumer electronics, and oil and gas customers. The company was originally founded in 1785 and was formerly known as Platform Specialty Products Corporation before adopting its current name in January 2019.
As a participant in the specialty chemicals sub-industry, Element Solutions competes in a market where products are typically sold based on performance characteristics and technical specifications rather than chemical composition, and where formulations are often tailored to individual customer applications. The business model relies on deep technical integration with customers manufacturing processes, which tends to create high switching costs and long product qualification cycles, particularly in electronics assembly and semiconductor packaging applications.
- Semiconductor packaging demand surges on AI server buildout
- Energy solutions revenue tracks offshore oil and gas activity
- China tariff exposure pressures specialty chemicals pricing
| Net Income: 178.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.17 > 1.0 |
| NWC/Revenue: 31.71% < 20% (prev 44.18%; Δ -12.47% < -1%) |
| CFO/TA 0.04 > 3% & CFO 218.1m > Net Income 178.6m |
| Net Debt (1.95b) to EBITDA (379.8m): 5.12 < 3 |
| Current Ratio: 2.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (243.9m) vs 12m ago 0.54% < -2% |
| Gross Margin: 38.42% > 18% (prev 41.82%; Δ -3.40% > 0.5%) |
| Asset Turnover: 58.41% > 50% (prev 49.74%; Δ 8.67% > 0%) |
| Interest Coverage Ratio: 3.02 > 6 (EBIT TTM 216.8m / Interest Expense TTM 71.7m) |
| A: 0.17 (Total Current Assets 1.52b - Total Current Liabilities 523.8m) / Total Assets 5.78b |
| B: -0.14 (Retained Earnings -811.2m / Total Assets 5.78b) |
| C: 0.04 (EBIT TTM 216.8m / Avg Total Assets 5.39b) |
| D: 0.95 (Book Value of Equity 2.81b / Total Liabilities 2.96b) |
| Altman-Z'' = 1.94 = BBB |
| DSRI: 1.13 (Receivables 711.0m/496.7m, Revenue 3.15b/2.49b) |
| GMI: 1.09 (GM 41.82% / 38.42%) |
| AQI: 1.02 (AQ_t 0.67 / AQ_t-1 0.65) |
| SGI: 1.27 (Revenue 3.15b / 2.49b) |
| TATA: -0.01 (NI 178.6m - CFO 218.1m) / TA 5.78b) |
| Beneish M = -2.63 (Cap -4..+1) = A |
As of August 23, 2026, the stock is trading at USD 35.31 with a total of 3,036,456 shares traded. Over the past week, the price has changed by -9.02%, over one month by -7.64%, over three months by -12.35% and over the past year by +42.78%.
Current recommended Stop Loss: 33.40 (which is 5.4% or 1.3 ATR below the current price).
Element Solutions has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy ESI.
- StrongBuy: 7
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 46.8 | 32.4% |
P/E Trailing = 50.3919
P/E Forward = 21.5517
P/S = 2.8847
P/B = 3.398
Revenue TTM = 3.15b USD
EBIT TTM = 216.8m USD
EBITDA TTM = 379.8m USD
Long Term Debt = 2.06b USD (from longTermDebt, last quarter)
Short Term Debt = 62.9m USD (from shortTermDebt, last quarter)
Debt = 2.14b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.5m
Net Debt = 1.95b USD (calculated: Debt 2.14b - CCE 189.6m)
Enterprise Value = 11.0b USD (9.09b + Debt 2.14b - CCE 189.6m)
Interest Coverage Ratio = 3.02 (Ebit TTM 216.8m / Interest Expense TTM 71.7m)
EV/FCF = 83.84x (Enterprise Value 11.0b / FCF TTM 131.6m)
FCF Yield = 1.19% (FCF TTM 131.6m / Enterprise Value 11.0b)
FCF Margin = 4.18% (FCF TTM 131.6m / Revenue TTM 3.15b)
Net Margin = 5.67% (Net Income TTM 178.6m / Revenue TTM 3.15b)
Gross Margin = 38.42% ((Revenue TTM 3.15b - Cost of Revenue TTM 1.94b) / Revenue TTM)
Gross Margin QoQ = 34.15% (prev 38.42%)
Tobins Q-Ratio = 1.91 (Enterprise Value 11.0b / Total Assets 5.78b)
Interest Expense / Debt = 3.36% (Interest Expense 71.7m / Debt 2.14b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 171.3m (EBIT 216.8m * (1 - 21.00%))
Current Ratio = 2.91 (Total Current Assets 1.52b / Total Current Liabilities 523.8m)
Debt / Equity = 0.76 (Debt 2.14b / totalStockholderEquity, last quarter 2.81b)
Debt / EBITDA = 5.12 (Net Debt 1.95b / EBITDA 379.8m)
Debt / FCF = 14.79 (Net Debt 1.95b / FCF TTM 131.6m)
Total Stockholder Equity = 2.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.31% (Net Income 178.6m / Total Assets 5.78b)
RoE = 6.57% (Net Income TTM 178.6m / Total Stockholder Equity 2.72b)
RoCE = 4.54% (EBIT 216.8m / Capital Employed (Equity 2.72b + L.T.Debt 2.06b))
RoIC = 3.32% (NOPAT 171.3m / Invested Capital 5.17b)
WACC = 10.32% (E(9.09b)/V(11.2b) * Re(12.12%) + D(2.14b)/V(11.2b) * Rd(3.36%) * (1-Tc(0.21)))
Discount Rate = 12.12% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.16 | Cagr: 0.26%
[DCF] Terminal Value 66.12% ; FCFF base≈187.8m ; Y1≈164.7m ; Y5≈133.1m
[DCF] Fair Price = N/A (negative equity: EV 1.62b - Net Debt 1.95b = -331.1m; debt exceeds intrinsic value)
EPS Correlation: 96.73 | EPS CAGR: 8.66% | SUE: 4.0 | # QB: 3
Revenue Correlation: 84.92 | Revenue CAGR: 8.68% | SUE: 2.54 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.47 | Chg30d=+1.53% | Revisions=+67% | Analysts=9
EPS current Year (2026-12-31): EPS=1.81 | Chg30d=+2.28% | Revisions=+58% | GrowthEPS=+21.5% | GrowthRev=+46.0%
EPS next Year (2027-12-31): EPS=2.08 | Chg30d=+1.36% | Revisions=+70% | GrowthEPS=+15.0% | GrowthRev=+7.5%
[Analyst] Revisions Ratio: +80% (up=21, down=1)